These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
495 related items for PubMed ID: 7640539
21. A population-based evaluation of the impact of antenatal screening for Down's syndrome in France, 1981-2000. Khoshnood B, De Vigan C, Vodovar V, Goujard J, Goffinet F. BJOG; 2004 May; 111(5):485-90. PubMed ID: 15104615 [Abstract] [Full Text] [Related]
24. Explaining variation in Down's syndrome screening uptake: comparing the Netherlands with England and Denmark using documentary analysis and expert stakeholder interviews. Crombag NM, Vellinga YE, Kluijfhout SA, Bryant LD, Ward PA, Iedema-Kuiper R, Schielen PC, Bensing JM, Visser GH, Tabor A, Hirst J. BMC Health Serv Res; 2014 Sep 25; 14():437. PubMed ID: 25257793 [Abstract] [Full Text] [Related]
25. Prenatal genetic services for Down's syndrome: access and provision in 1990-1991. Steering Committee of the National Confidential Enquiry into Counselling for Genetic Disorders. Williamson P, Harris R, Church S, Fiddler M, Rhind J. Br J Obstet Gynaecol; 1996 Jul 25; 103(7):676-83. PubMed ID: 8688395 [Abstract] [Full Text] [Related]
26. Down's syndrome: current screening techniques. White RS. South Med J; 1989 Dec 25; 82(12):1483-6. PubMed ID: 2480649 [Abstract] [Full Text] [Related]
29. An economic appraisal of alternative pre-natal screening programmes for Down's syndrome. Shackley P, McGuire A, Boyd PA, Dennis J, Fitchett M, Kay J, Roche M, Wood P. J Public Health Med; 1993 Jun 25; 15(2):175-84. PubMed ID: 7688977 [Abstract] [Full Text] [Related]
33. The effect of differences in the distribution of maternal age in England and Wales on the performance of prenatal screening for Down's syndrome. Huang T, Watt HC, Wald NJ. Prenat Diagn; 1997 Jul 25; 17(7):615-21. PubMed ID: 9249861 [Abstract] [Full Text] [Related]
34. Risk assessment adjusted for gestational age in maternal serum screening for Down's syndrome. Gardosi J, Mongelli M. BMJ; 1993 Jun 05; 306(6891):1509-11. PubMed ID: 8518678 [Abstract] [Full Text] [Related]
35. [Screening by maternal serum markers for Down's syndrome]. Liu JT, Hao N, Sun NH, Wang FY, Xu YH, Gai MY, Bian XM, Yang JQ. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr 05; 25(2):156-9. PubMed ID: 12905710 [Abstract] [Full Text] [Related]
36. Screening for Down's syndrome using an iso-risk curve based on maternal age and serum alpha-fetoprotein level. Tabor A, Larsen SO, Nielsen J, Nielsen J, Philip J, Pilgaard B, Videbech P, Nørgaard-Pedersen B. Br J Obstet Gynaecol; 1987 Jul 05; 94(7):636-42. PubMed ID: 2441737 [Abstract] [Full Text] [Related]
37. Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels. DiMaio MS, Baumgarten A, Greenstein RM, Saal HM, Mahoney MJ. N Engl J Med; 1987 Aug 06; 317(6):342-6. PubMed ID: 2439909 [Abstract] [Full Text] [Related]
38. Second trimester screening for Down's syndrome: 7 years experience. Beaman JM, Goldie DJ. J Med Screen; 2001 Aug 06; 8(3):128-31. PubMed ID: 11678551 [Abstract] [Full Text] [Related]